DD126930A5 - - Google Patents

Info

Publication number
DD126930A5
DD126930A5 DD195242A DD19524276A DD126930A5 DD 126930 A5 DD126930 A5 DD 126930A5 DD 195242 A DD195242 A DD 195242A DD 19524276 A DD19524276 A DD 19524276A DD 126930 A5 DD126930 A5 DD 126930A5
Authority
DD
German Democratic Republic
Application number
DD195242A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD126930A5 publication Critical patent/DD126930A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/852Klebsiella
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DD195242A 1975-10-13 1976-10-12 DD126930A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41898/75A GB1563103A (en) 1975-10-13 1975-10-13 Process for the preparation of clavulanic acid

Publications (1)

Publication Number Publication Date
DD126930A5 true DD126930A5 (en:Method) 1977-08-24

Family

ID=10421869

Family Applications (1)

Application Number Title Priority Date Filing Date
DD195242A DD126930A5 (en:Method) 1975-10-13 1976-10-12

Country Status (26)

Country Link
US (1) US4072569A (en:Method)
JP (1) JPS6057834B2 (en:Method)
AR (1) AR211031A1 (en:Method)
AT (1) AT354624B (en:Method)
AU (1) AU503529B2 (en:Method)
BE (1) BE846933A (en:Method)
CA (1) CA1072471A (en:Method)
CH (1) CH629532A5 (en:Method)
DD (1) DD126930A5 (en:Method)
DE (1) DE2646001A1 (en:Method)
DK (1) DK457576A (en:Method)
ES (1) ES452363A1 (en:Method)
FI (1) FI762909A7 (en:Method)
FR (1) FR2328045A1 (en:Method)
GB (1) GB1563103A (en:Method)
GR (1) GR61646B (en:Method)
IE (1) IE43801B1 (en:Method)
IL (1) IL50527A (en:Method)
NL (1) NL7611204A (en:Method)
NO (1) NO763474L (en:Method)
NZ (1) NZ182120A (en:Method)
PL (1) PL105494B1 (en:Method)
SE (1) SE434065B (en:Method)
SU (1) SU695565A3 (en:Method)
YU (1) YU251776A (en:Method)
ZA (1) ZA765702B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4155912A (en) 1977-12-14 1979-05-22 Bristol-Myers Company 2-Methylpenem-3-carboxylic acid antibiotics
US4182711A (en) 1978-04-27 1980-01-08 Bristol-Myers Company Antibacterial agents of the β-lactam type
US4272437A (en) 1978-12-18 1981-06-09 Bristol-Myers Company Antibacterial agents, and 4-thio azetidinone intermediates
US4282150A (en) 1978-12-18 1981-08-04 Bristol-Myers Company 2,6-Disubstituted penem compounds
US4378314A (en) 1979-09-21 1983-03-29 Bristol Myers Company Antibacterial agents and metal containing azetidinone intermediates therefore
US4374065A (en) 1979-09-21 1983-02-15 Bristol-Myers Company Antibacterial agents of the β-lactam type
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500265A1 (en) * 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
SI9600120A (en) * 1996-04-12 1997-12-31 Lek Tovarna Farmacevtskih New and improved fermentative procedure for the production of clavulanic acid and its salts
AR015825A1 (es) * 1997-05-28 2001-05-30 Gist Brocades Bv Produccion fermentativa de acido clavulanico bajo condiciones controladas de fosfato
US6440708B1 (en) 1998-09-29 2002-08-27 Dsm N.V. Fermentation of clavulanic acid at a controlled level of ammonia
CA2364342C (en) * 1999-04-01 2011-02-01 Dsm N.V. Agglomerates by crystallisation
CA2669931A1 (en) * 2006-12-01 2008-06-05 Dsm Ip Assets B.V. Process for the production of clavulanic acid
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5318595B2 (en:Method) * 1972-08-31 1978-06-15
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions

Also Published As

Publication number Publication date
IL50527A0 (en) 1976-11-30
GR61646B (en) 1978-12-05
AT354624B (de) 1979-01-25
NZ182120A (en) 1979-03-16
DE2646001A1 (de) 1977-04-21
JPS6057834B2 (ja) 1985-12-17
NL7611204A (nl) 1977-04-15
FR2328045A1 (fr) 1977-05-13
YU251776A (en) 1982-06-30
CH629532A5 (de) 1982-04-30
GB1563103A (en) 1980-03-19
ZA765702B (en) 1977-09-28
PL105494B1 (pl) 1979-10-31
SE434065B (sv) 1984-07-02
ES452363A1 (es) 1978-01-01
AR211031A1 (es) 1977-10-14
AU503529B2 (en) 1979-09-06
JPS5247991A (en) 1977-04-16
IL50527A (en) 1979-05-31
DK457576A (da) 1977-04-14
CA1072471A (en) 1980-02-26
ATA753276A (de) 1979-06-15
BE846933A (fr) 1977-04-04
IE43801B1 (en) 1981-06-03
FR2328045B1 (en:Method) 1980-01-04
SE7611046L (sv) 1977-04-14
AU1855576A (en) 1978-04-20
SU695565A3 (ru) 1979-10-30
NO763474L (en:Method) 1977-04-14
IE43801L (en) 1977-04-13
FI762909A7 (en:Method) 1977-04-14
US4072569A (en) 1978-02-07

Similar Documents

Publication Publication Date Title
FR2322789B3 (en:Method)
FR2314730B1 (en:Method)
FR2328045B1 (en:Method)
FR2304646B1 (en:Method)
JPS5246326U (en:Method)
JPS556859B2 (en:Method)
JPS522404U (en:Method)
JPS5241735U (en:Method)
FR2327276B1 (en:Method)
JPS5529144Y2 (en:Method)
JPS5286639U (en:Method)
JPS5244324U (en:Method)
JPS5235062U (en:Method)
JPS5290539U (en:Method)
JPS5195378A (en:Method)
JPS51156511U (en:Method)
JPS51145092U (en:Method)
JPS529208U (en:Method)
CH601370A5 (en:Method)
CH602169A5 (en:Method)
CH601881A5 (en:Method)
CH601528A5 (en:Method)
CH596978A5 (en:Method)
CH600721A5 (en:Method)
CH600530A5 (en:Method)